Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Cell Biology International
|
November 19, 2017
PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines
Hai Qian, Yan Tao, Lu Jiang, et al.
Therapeutic Advances in Medical Oncology
|
February 14, 2018
The constitutively active PKG II mutant effectively inhibits gastric cancer development <i>via</i> a blockade of EGF/EGFR-associated signalling cascades
Yan Wu, Miaomiao Yuan, Wenbin Su, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 6, 2018
Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?
Yan Wu, Ying Liu, Zhensheng Cai, et al.
Analytical Chemistry
|
December 14, 2025
Multifunctional Composite Coating-Enhanced Flexible Microelectrodes for Chronic, High-Fidelity Neural Signal Recording
Ji Pang, Yuyang Sun, Tingting Cheng, et al.
Frontiers in Bioscience (Landmark Edition)
|
February 28, 2022
PKG II secreted via the classical endoplasmic reticulum-Golgi apparatus secretory pathway blocks the activation of EGFR through phosporalting its threonine 406 and has an anti-tumor effect
Yan Wu, Min Wu, Zibin Wang, et al.
Cell Reports
|
January 13, 2021
NOTCH Signaling Controls Ciliary Body Morphogenesis and Secretion by Directly Regulating Nectin Protein Expression
Ji Pang, Liang Le, Yi Zhou, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Cell Biology International
|
November 19, 2017
PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines
Hai Qian, Yan Tao, Lu Jiang, et al.
Therapeutic Advances in Medical Oncology
|
February 14, 2018
The constitutively active PKG II mutant effectively inhibits gastric cancer development <i>via</i> a blockade of EGF/EGFR-associated signalling cascades
Yan Wu, Miaomiao Yuan, Wenbin Su, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 6, 2018
Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?
Yan Wu, Ying Liu, Zhensheng Cai, et al.
Analytical Chemistry
|
December 14, 2025
Multifunctional Composite Coating-Enhanced Flexible Microelectrodes for Chronic, High-Fidelity Neural Signal Recording
Ji Pang, Yuyang Sun, Tingting Cheng, et al.
Frontiers in Bioscience (Landmark Edition)
|
February 28, 2022
PKG II secreted via the classical endoplasmic reticulum-Golgi apparatus secretory pathway blocks the activation of EGFR through phosporalting its threonine 406 and has an anti-tumor effect
Yan Wu, Min Wu, Zibin Wang, et al.
Cell Reports
|
January 13, 2021
NOTCH Signaling Controls Ciliary Body Morphogenesis and Secretion by Directly Regulating Nectin Protein Expression
Ji Pang, Liang Le, Yi Zhou, et al.
Page
of 3